Similar articles for PMID: 28713881

Year	Number of Results
2004	3
2005	2
2007	3
2008	1
2010	2
2011	4
2013	4
2014	2
2015	7
2016	9
2017	6
2018	8
2019	6
2024	0

1

Drug Delivery and Nanoformulations for the Cardiovascular System.

Geldenhuys WJ, Khayat MT, Yun J, Nayeem MA. Geldenhuys WJ, et al. Res Rev Drug Deliv. 2017 Feb;1(1):32-40. Epub 2017 Mar 7. Res Rev Drug Deliv. 2017. PMID: 28713881 Free PMC article.

2

Effect of Soluble Epoxide Hydrolase on the Modulation of Coronary Reactive Hyperemia: Role of Oxylipins and PPARγ.

Hanif A, Edin ML, Zeldin DC, Morisseau C, Nayeem MA. Hanif A, et al. PLoS One. 2016 Sep 1;11(9):e0162147. doi: 10.1371/journal.pone.0162147. eCollection 2016. PLoS One. 2016. PMID: 27583776 Free PMC article.

3

The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases.

Xu X, Zhang XA, Wang DW. Xu X, et al. Adv Drug Deliv Rev. 2011 Jul 18;63(8):597-609. doi: 10.1016/j.addr.2011.03.006. Epub 2011 Apr 6. Adv Drug Deliv Rev. 2011. PMID: 21477627 Review.

4

Inhibitors of soluble epoxide hydrolase minimize ischemia-reperfusion-induced cardiac damage in normal, hypertensive, and diabetic rats.

Islam O, Patil P, Goswami SK, Razdan R, Inamdar MN, Rizwan M, Mathew J, Inceoglu B, Stephen Lee KS, Hwang SH, Hammock BD. Islam O, et al. Cardiovasc Ther. 2017 Jun;35(3):10.1111/1755-5922.12259. doi: 10.1111/1755-5922.12259. Cardiovasc Ther. 2017. PMID: 28296232 Free PMC article.

5

Recent progress of drug nanoformulations targeting to brain.

Khan AR, Yang X, Fu M, Zhai G. Khan AR, et al. J Control Release. 2018 Dec 10;291:37-64. doi: 10.1016/j.jconrel.2018.10.004. Epub 2018 Oct 9. J Control Release. 2018. PMID: 30308256 Review.

6

Nanoparticle Based Treatment for Cardiovascular Diseases.

Gupta P, Garcia E, Sarkar A, Kapoor S, Rafiq K, Chand HS, Jayant RD. Gupta P, et al. Cardiovasc Hematol Disord Drug Targets. 2019;19(1):33-44. doi: 10.2174/1871529X18666180508113253. Cardiovasc Hematol Disord Drug Targets. 2019. PMID: 29737265 Review.

7

High salt diet modulates vascular response in A2AAR (+/+) and A 2AAR (-/-) mice: role of sEH, PPARγ, and K ATP channels.

Pradhan I, Ledent C, Mustafa SJ, Morisseau C, Nayeem MA. Pradhan I, et al. Mol Cell Biochem. 2015 Jun;404(1-2):87-96. doi: 10.1007/s11010-015-2368-4. Epub 2015 Mar 5. Mol Cell Biochem. 2015. PMID: 25739357 Free PMC article.

8

Cardiovascular therapies utilizing targeted delivery of nanomedicines and aptamers.

Tan KX, Pan S, Jeevanandam J, Danquah MK. Tan KX, et al. Int J Pharm. 2019 Mar 10;558:413-425. doi: 10.1016/j.ijpharm.2019.01.023. Epub 2019 Jan 18. Int J Pharm. 2019. PMID: 30660748 Review.

9

Role of central and peripheral adenosine receptors in the cardiovascular responses to intraperitoneal injections of adenosine A1 and A2A subtype receptor agonists.

Schindler CW, Karcz-Kubicha M, Thorndike EB, Müller CE, Tella SR, Ferré S, Goldberg SR. Schindler CW, et al. Br J Pharmacol. 2005 Mar;144(5):642-50. doi: 10.1038/sj.bjp.0706043. Br J Pharmacol. 2005. PMID: 15678095 Free PMC article.

10

Nanobiotechnology-based drug delivery in brain targeting.

Dinda SC, Pattnaik G. Dinda SC, et al. Curr Pharm Biotechnol. 2013;14(15):1264-74. doi: 10.2174/1389201015666140608143719. Curr Pharm Biotechnol. 2013. PMID: 24910011 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

56 results

Results by year